Aviva’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $482K | Sell |
6,563
-3,805
| -37% | -$279K | ﹤0.01% | 764 |
|
2025
Q1 | $1.18M | Sell |
10,368
-588
| -5% | -$67.2K | ﹤0.01% | 613 |
|
2024
Q4 | $552K | Sell |
10,956
-6,371
| -37% | -$321K | ﹤0.01% | 785 |
|
2024
Q3 | $802K | Sell |
17,327
-3,893
| -18% | -$180K | ﹤0.01% | 626 |
|
2024
Q2 | $689K | Sell |
21,220
-5,265
| -20% | -$171K | ﹤0.01% | 680 |
|
2024
Q1 | $667K | Buy |
26,485
+4,072
| +18% | +$103K | ﹤0.01% | 749 |
|
2023
Q4 | $728K | Buy |
+22,413
| New | +$728K | ﹤0.01% | 724 |
|
2022
Q1 | – | Sell |
-127,855
| Closed | -$2.53M | – | 1069 |
|
2021
Q4 | $2.53M | Buy |
127,855
+48,808
| +62% | +$967K | 0.01% | 791 |
|
2021
Q3 | $1.56M | Buy |
+79,047
| New | +$1.56M | 0.01% | 876 |
|
2021
Q1 | – | Sell |
-70,676
| Closed | -$1.85M | – | 950 |
|
2020
Q4 | $1.85M | Sell |
70,676
-57,297
| -45% | -$1.5M | 0.01% | 691 |
|
2020
Q3 | $2.23M | Sell |
127,973
-8,376
| -6% | -$146K | 0.01% | 737 |
|
2020
Q2 | $2.29M | Sell |
136,349
-180,494
| -57% | -$3.04M | 0.01% | 699 |
|
2020
Q1 | $3.77M | Buy |
+316,843
| New | +$3.77M | 0.03% | 506 |
|